• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Responding to growth through HR and payroll outsourcing

Article

The decision to seek HR and payroll outsourcing services for SomerfordCorp.'s 13 assisted living facilities was directly related to growth. Theacquisition of a California-based healthcare provider in October, 2001,doubled Somerford's employee population and added six facilities to thecompany, and also increased the complexity of HR management.

The decision to seek HR and payroll outsourcing services for SomerfordCorp.'s 13 assisted living facilities was directly related to growth. Theacquisition of a California-based healthcare provider in October, 2001,doubled Somerford's employee population and added six facilities to thecompany, and also increased the complexity of HR management.

"We knew we needed more control over our information, as well asan integrated HR, payroll, and benefits solution," says Judy Huber,vice president of finance and administration. "However, we also knewwe didn't want the cost or staffing requirements associated with managingan HR/payroll/benefits system infrastructure in house. Moving to a HR businessprocessing outsourcing provider was the logical choice for us."

Huber appointed Idalee DiGregorio, director of human resources for Somerford,to select an outsourcing provider, lead the conversion process, and managethe new relationship.

"In addition to identifying vendors who offered a full range ofservices, we also needed to find a vendor that matched our own corporateculture," DiGregorio says.

After evaluating more than 10 outsourcing vendors, large and small, Somerfordselected Genesys. Selection criteria included: experience with a Web-basedsolution; demonstrated technical expertise; assignment of designated accountmanagers; a comprehensive portfolio of services; cost; and a company whosesize matched to Somerford's needs.

"In the end, it's the relationships between people that make a decisionsuccessful," Huber says. "Companies should look for a vendor thathas a philosophy similar to their own. And vendors should make sure theyidentify the specific needs and concerns of a prospect, and not assume allcompanies are the same."

 

About the Author

Ruth Ladner is COO at Genesys.

Somerford Corp. is a provider of assisted living and Alzheimer's carewith 13 facilities located throughout California, Delaware, and Maryland.

Related Videos
Video 3 - "In-Office Procedures, Over-the-Counter Options, Treatment Delays, and Costs"
Video 6 - "Safety Analysis and Interpreting Results from MAJIC-PV"
Video 5 - "Key Findings from MAJIC-PV"
Video 2 - "Traditional Treatment of Demodex Blepharitis, FDA approval, and Lotilaner Ophthalmic Solution, 0.25%"
Gabriela Hobbs, MD, an expert on polycythemia vera
Gabriela Hobbs, MD, and Timothy Mok, PharmD, BCPS, BCOP
Video 1 - "Demodex Blepharitis: Prevalence, Symptoms, Quality of Life Impact, and Diagnosis"
Video 2 - "The Role of Ruxolitinib in Managing Hydroxyurea Resistance or Intolerance"
Video 1 - "Prevalence and Impact of Hydroxyurea Intolerance or Resistance in Polycythemia Vera"
Related Content
© 2024 MJH Life Sciences

All rights reserved.